Patent ID: 9217742
Filing Date: 2015-12-22
Classification: A61P,G01N

Abstract:
1. A method for assessing the risk of future cardiovascular events in an individual with stable coronary artery disease (CAD), the method comprising: (a) contacting a blood, plasma, or serum sample from the individual with antibodies of a dual antibody assay for the determination of PCT with a functional assay sensitivity of <0.007 ng/ml PCT to determine the level of procalcitonin (PCT) in said plasma or serum sample from the individual; (b) determining the level of brain natriuretic protein (BNP) in said sample; and (c) identifying the individual as being at highest risk of experiencing future adverse cardiovascular events when the PCT level is equal to or greater than 0.05 ng/ml and the BNP level is greater than 99.4 pg/ml.